Truist Financial Corp increased its holdings in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 22.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,570 shares of the company's stock after acquiring an additional 6,454 shares during the quarter. Truist Financial Corp owned approximately 0.65% of Nutex Health worth $1,127,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Drive Wealth Management LLC purchased a new position in shares of Nutex Health in the fourth quarter worth $1,122,000. Legato Capital Management LLC increased its holdings in Nutex Health by 26.8% in the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after buying an additional 6,697 shares during the period. Baader Bank Aktiengesellschaft acquired a new stake in Nutex Health during the 4th quarter valued at approximately $206,000. International Assets Investment Management LLC purchased a new stake in Nutex Health in the third quarter valued at $188,000. Finally, State Street Corp purchased a new position in shares of Nutex Health during the 3rd quarter valued at approximately $225,000. 5.32% of the stock is currently owned by institutional investors.
Nutex Health Stock Down 11.0 %
NASDAQ:NUTX traded down $5.68 during midday trading on Tuesday, reaching $46.01. The company had a trading volume of 82,377 shares, compared to its average volume of 47,465. Nutex Health Inc. has a 12-month low of $4.16 and a 12-month high of $69.45. The firm has a market capitalization of $250.16 million, a price-to-earnings ratio of -4.90 and a beta of 0.20. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The stock's fifty day simple moving average is $45.29 and its 200-day simple moving average is $32.84.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on the stock. Maxim Group increased their target price on shares of Nutex Health from $50.00 to $75.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Benchmark raised their price objective on Nutex Health from $45.00 to $60.00 and gave the stock a "buy" rating in a research report on Tuesday, November 12th.
Get Our Latest Research Report on Nutex Health
Nutex Health Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Stories
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
